XML 27 R11.htm IDEA: XBRL DOCUMENT
v3.20.4

Condensed Statements of Cash Flows (Brooklyn ImmunoTherapeutics, LLC) - USD ($) | 2 Months Ended | 3 Months Ended | 9 Months Ended | 10 Months Ended | 12 Months Ended
--- | --- | --- | --- | --- | ---
Dec. 31, 2018 | Dec. 31, 2018 | Sep. 30, 2020 | Sep. 30, 2019 | Sep. 30, 2020 | Sep. 30, 2019 | Nov. 05, 2018 | Dec. 31, 2019 | Dec. 31, 2018
Cash Flows from Operating Activities |  |  |  |  |  |  |  |  |
Net loss |  |  | $ (1,481,000) | $ (351,000) | $ (4,722,000) | $ (754,000) |  | $ (2,047,000) | $ (259,000)
Adjustments to reconcile net loss to net cash used in operating activities: |  |  |  |  |  |  |  |  |
Depreciation and amortization |  |  | 26,000 | 88,000 | 189,000 | 273,000 |  | 360,000 | 315,000
Equity compensation |  |  | 53,000 | 63,000 | 135,000 | 172,000 |  | 206,000 | 443,000
Change in operating assets and liabilities: |  |  |  |  |  |  |  |  |
Accounts payable and accrued expenses |  |  |  |  | (1,405,000) | (196,000) |  | 669,000 | (186,000)
Other liabilities |  |  |  |  | (291,000) | (141,000) |  | 108,000 | 41,000
Net cash (used in) provided by operating activities |  |  |  |  | (3,280,000) | 1,761,000 |  | 2,744,000 | 1,365,000
Cash Flows from Investing Activities: |  |  |  |  |  |  |  |  |
Net Cash Provided by (Used in) Investing Activities |  |  |  |  | (194,000) | (964,000) |  | (1,065,000) | (1,579,000)
Cash Flows from Financing Activities: |  |  |  |  |  |  |  |  |
Net cash provided by (used in) financing activities |  |  |  |  | 1,765,000 | (826,000) |  | (1,098,000) | (303,000)
Net decrease in cash, cash equivalents and restricted cash |  |  |  |  | (1,699,000) | (2,000) |  | 623,000 | (592,000)
Cash, cash equivalents and restricted cash at beginning of period |  |  |  |  | 3,409,000 | 2,786,000 | $ 3,378,000 | 2,786,000 | 3,378,000
Cash, cash equivalents and restricted cash at end of period | $ 2,786,000 | $ 2,786,000 | 1,710,000 | 2,784,000 | 1,710,000 | 2,784,000 |  | 3,409,000 | 2,786,000
Cash and Restricted Cash consisted of the following: |  |  |  |  |  |  |  |  |
Restricted cash | 50,000 | 50,000 |  | 51,000 |  | 51,000 |  | 50,000 | 50,000
Supplemental Disclosures of Cash Flow Information: |  |  |  |  |  |  |  |  |
Cash paid during the period for : Interest |  |  |  |  | 86,000 | 195,000 |  | 246,000 | 336,000
Cash paid during the period for : Income taxes |  |  |  |  | 23,000 | 26,000 |  | 26,000 | 17,000
Brooklyn Immunotherapeutics, LLC [Member] |  |  |  |  |  |  |  |  |
Cash Flows from Operating Activities |  |  |  |  |  |  |  |  |
Net loss |  |  |  |  | (5,072,803) | (6,134,389) |  | 8,937,054 |
Adjustments to reconcile net loss to net cash used in operating activities: |  |  |  |  |  |  |  |  |
Depreciation and amortization |  |  |  |  | 72,909 | 7,917 |  |  |
Equity compensation |  |  |  |  | 68,202 | 68,674 |  |  |
Loss on operating sublease |  |  |  |  |  |  |  |  |
Change in operating assets and liabilities: |  |  |  |  |  |  |  |  |
Prepaid expenses and other current assets |  |  |  |  | (69,240) | (62,240) |  |  |
Security deposits |  |  |  |  | (84,914) |  |  |  |
Accounts payable and accrued expenses |  |  |  |  | (1,392,925) | (2,134,303) |  |  |
Lease liability |  |  |  |  | (2,356) |  |  |  |
Other liabilities |  |  |  |  | 17,842 | 52,254 |  |  |
Total adjustments |  |  |  |  | (1,390,482) | (2,067,698) |  |  |
Net cash (used in) provided by operating activities |  |  |  |  | (6,463,285) | (8,202,087) |  | 9,800,291 | 18,436,717
Cash Flows from Investing Activities: |  |  |  |  |  |  |  |  |
Patent costs |  |  |  |  |  |  |  |  |
Purchase of property and equipment |  |  |  |  | (26,177) | (8,756) |  |  |
Purchase of leasehold improvements |  |  |  |  |  | (100,000) |  |  |
Purchase of IRX - cash and restricted cash acquired |  |  |  |  |  |  |  |  |
Net Cash Provided by (Used in) Investing Activities |  |  |  |  | (26,177) | (108,756) |  |  |
Cash Flows from Financing Activities: |  |  |  |  |  |  |  |  |
Proceeds from loans payable |  |  |  |  | 309,905 |  |  |  |
Proceeds from loans payable, related parties |  |  |  |  |  |  |  |  |
Proceeds from convertible debt |  |  |  |  |  |  |  |  |
Proceeds from investor deposits |  |  |  |  |  |  |  | 437,500 |
Proceeds from the collection of subscriptions receivable |  |  |  |  | 275,000 | 850,000 |  | 850,000 |
Proceeds from sale of members' equity |  |  |  |  | 3,858,750 | 7,395,750 |  | 7,808,250 |
Net cash provided by (used in) financing activities |  |  |  |  | 4,443,655 | 8,245,750 |  |  |
Net decrease in cash, cash equivalents and restricted cash |  |  |  |  | (2,045,807) | (65,093) |  |  |
Cash, cash equivalents and restricted cash at beginning of period |  |  |  |  | 5,100,819 | 6,411,431 |  | 6,411,431 |
Cash, cash equivalents and restricted cash at end of period | 6,411,431 | 6,411,431 | 3,055,012 | 6,346,338 | 3,055,012 | 6,346,338 |  | 5,100,819 | 6,411,431
Cash and Restricted Cash consisted of the following: |  |  |  |  |  |  |  |  |
Cash | 6,325,431 | 6,325,431 | 3,055,012 | 6,260,338 | 3,055,012 | 6,260,338 |  | 5,014,819 | 6,325,431
Restricted cash | 86,000 | 86,000 |  | 86,000 |  | 86,000 |  | 86,000 | 86,000
Cash and Restricted Cash Equivalents |  |  | $ 3,055,012 | $ 6,346,338 | 3,055,012 | 6,346,338 |  |  |
Supplemental Disclosures of Cash Flow Information: |  |  |  |  |  |  |  |  |
Cash paid during the period for : Interest |  |  |  |  |  |  |  |  |
Cash paid during the period for : Income taxes |  |  |  |  |  |  |  |  |
Brooklyn Immunotherapeutics, LLC [Member] | Successor [Member] |  |  |  |  |  |  |  |  |
Cash Flows from Operating Activities |  |  |  |  |  |  |  |  |
Net loss | (2,004,472) |  |  |  |  |  |  | (8,937,054) |
Adjustments to reconcile net loss to net cash used in operating activities: |  |  |  |  |  |  |  |  |
Depreciation and amortization | 1,498 |  |  |  |  |  |  | 20,407 |
Equity compensation | 20,248 | 20,248 |  |  |  |  |  | 91,689 |
Loss on operating sublease |  |  |  |  |  |  |  | 103,350 |
Change in operating assets and liabilities: |  |  |  |  |  |  |  |  |
Prepaid expenses and other current assets |  |  |  |  |  |  |  | (66,670) |
Security deposits |  |  |  |  |  |  |  | 76,155 |
Accounts payable and accrued expenses | (168,298) |  |  |  |  |  |  | (1,087,874) |
Lease liability |  |  |  |  |  |  |  | (294) |
Other liabilities |  |  |  |  |  |  |  |  |
Total adjustments | (146,552) |  |  |  |  |  |  | (863,237) |
Net cash (used in) provided by operating activities | (2,151,024) |  |  |  |  |  |  | (9,800,291) |
Cash Flows from Investing Activities: |  |  |  |  |  |  |  |  |
Patent costs |  |  |  |  |  |  |  |  |
Purchase of property and equipment |  |  |  |  |  |  |  | (606,071) |
Purchase of IRX - cash and restricted cash acquired | 336,296 |  |  |  |  |  |  |  |
Net Cash Provided by (Used in) Investing Activities | 336,296 |  |  |  |  |  |  | (606,071) |
Cash Flows from Financing Activities: |  |  |  |  |  |  |  |  |
Proceeds from loans payable |  |  |  |  |  |  |  |  |
Proceeds from loans payable, related parties |  |  |  |  |  |  |  |  |
Proceeds from convertible debt |  |  |  |  |  |  |  |  |
Proceeds from investor deposits |  |  |  |  |  |  |  | 437,500 |
Proceeds from the collection of subscriptions receivable |  |  |  |  |  |  |  | 850,000 |
Proceeds from sale of members' equity | 1,744,154 |  |  |  |  |  |  | 7,808,250 |
Net cash provided by (used in) financing activities | 1,744,154 |  |  |  |  |  |  | 9,095,750 |
Net decrease in cash, cash equivalents and restricted cash | (70,574) |  |  |  |  |  |  | (1,310,612) |
Cash, cash equivalents and restricted cash at beginning of period | 6,482,005 |  |  |  | $ 5,100,819 | $ 6,411,431 |  | 6,411,431 |
Cash, cash equivalents and restricted cash at end of period | 6,411,431 | 6,411,431 |  |  |  |  |  | 5,100,819 | 6,411,431
Cash and Restricted Cash consisted of the following: |  |  |  |  |  |  |  |  |
Cash | 6,325,431 | 6,325,431 |  |  |  |  |  | 5,014,819 | 6,325,431
Restricted cash | 86,000 | 86,000 |  |  |  |  |  | 86,000 | 86,000
Cash and Restricted Cash Equivalents | 6,411,431 | 6,411,431 |  |  |  |  |  | 5,100,819 | 6,411,431
Supplemental Disclosures of Cash Flow Information: |  |  |  |  |  |  |  |  |
Cash paid during the period for : Interest |  |  |  |  |  |  |  |  |
Cash paid during the period for : Income taxes |  |  |  |  |  |  |  |  |
Non-cash investing and financing activities: |  |  |  |  |  |  |  |  |
Investor deposits for sale of members' equity |  |  |  |  |  |  |  | 410,512 |
Conversion of loans payable and interest into members' equity | 1,516,346 |  |  |  |  |  |  |  |
Exchange of Series A, B and C preferred stock for common stock |  |  |  |  |  |  |  |  |
Assets acquired and liabilities assumed: |  |  |  |  |  |  |  |  |
Cash acquired | 336,296 |  |  |  |  |  |  |  |
Prepaid expenses and other current assets | 19,998 |  |  |  |  |  |  |  |
Security deposits and other assets | 379,331 |  |  |  |  |  |  |  |
Goodwill | 2,043,747 |  |  |  |  |  |  |  |
In-process R&D | 6,860,000 |  |  |  |  |  |  |  |
Property and equipment | 69,597 |  |  |  |  |  |  |  |
Accounts payable and accrued expenses | (4,528,969) |  |  |  |  |  |  |  |
Loans payable, related parties | (1,500,000) |  |  |  |  |  |  |  |
Loans payable | (410,000) |  |  |  |  |  |  |  |
Total purchase price | 3,270,000 |  |  |  |  |  |  |  |
Purchase price consisted of: |  |  |  |  |  |  |  |  |
Members' equity issued to acquire the asset and liabilities of IRX | 2,400,000 |  |  |  |  |  |  |  |
Contingent consideration | 870,000 |  |  |  |  |  |  |  |
Total purchase price | $ 3,270,000 |  |  |  |  |  |  |  |
Brooklyn Immunotherapeutics, LLC [Member] | Predecessor [Member] |  |  |  |  |  |  |  |  |
Cash Flows from Operating Activities |  |  |  |  |  |  |  |  |
Net loss |  |  |  |  |  |  | (16,098,602) |  |
Adjustments to reconcile net loss to net cash used in operating activities: |  |  |  |  |  |  |  |  |
Depreciation and amortization |  |  |  |  |  |  | 136,314 |  |
Equity compensation |  |  |  |  |  |  |  |  |
Loss on operating sublease |  |  |  |  |  |  |  |  |
Change in operating assets and liabilities: |  |  |  |  |  |  |  |  |
Prepaid expenses and other current assets |  |  |  |  |  |  | (69,099) |  |
Security deposits |  |  |  |  |  |  | 8,001 |  |
Accounts payable and accrued expenses |  |  |  |  |  |  | (300,034) |  |
Lease liability |  |  |  |  |  |  |  |  |
Other liabilities |  |  |  |  |  |  | 37,727 |  |
Total adjustments |  |  |  |  |  |  | (187,091) |  |
Net cash (used in) provided by operating activities |  |  |  |  |  |  | (16,285,693) |  | 16,285,693
Cash Flows from Investing Activities: |  |  |  |  |  |  |  |  |
Patent costs |  |  |  |  |  |  | (172,196) |  |
Purchase of property and equipment |  |  |  |  |  |  | (76,485) |  |
Purchase of IRX - cash and restricted cash acquired |  |  |  |  |  |  |  |  |
Net Cash Provided by (Used in) Investing Activities |  |  |  |  |  |  | (248,681) |  |
Cash Flows from Financing Activities: |  |  |  |  |  |  |  |  |
Proceeds from loans payable |  |  |  |  |  |  | 3,394,226 |  |
Proceeds from loans payable, related parties |  |  |  |  |  |  | 1,500,000 |  |
Proceeds from convertible debt |  |  |  |  |  |  | 11,803,321 |  |
Proceeds from investor deposits |  |  |  |  |  |  |  |  |
Proceeds from the collection of subscriptions receivable |  |  |  |  |  |  |  |  |
Proceeds from sale of members' equity |  |  |  |  |  |  |  |  |
Net cash provided by (used in) financing activities |  |  |  |  |  |  | 16,697,547 |  |
Net decrease in cash, cash equivalents and restricted cash |  |  |  |  |  |  | 163,173 |  |
Cash, cash equivalents and restricted cash at beginning of period |  | $ 336,296 |  |  |  |  | 173,123 |  | $ 173,123
Cash, cash equivalents and restricted cash at end of period |  |  |  |  |  |  | 336,296 |  |
Cash and Restricted Cash consisted of the following: |  |  |  |  |  |  |  |  |
Cash |  |  |  |  |  |  | 250,296 |  |
Restricted cash |  |  |  |  |  |  | 86,000 |  |
Cash and Restricted Cash Equivalents |  |  |  |  |  |  | 336,296 |  |
Supplemental Disclosures of Cash Flow Information: |  |  |  |  |  |  |  |  |
Cash paid during the period for : Interest |  |  |  |  |  |  |  |  |
Cash paid during the period for : Income taxes |  |  |  |  |  |  |  |  |
Non-cash investing and financing activities: |  |  |  |  |  |  |  |  |
Investor deposits for sale of members' equity |  |  |  |  |  |  |  |  |
Conversion of loans payable and interest into members' equity |  |  |  |  |  |  |  |  |
Exchange of Series A, B and C preferred stock for common stock |  |  |  |  |  |  | 106,560,811 |  |
Assets acquired and liabilities assumed: |  |  |  |  |  |  |  |  |
Cash acquired |  |  |  |  |  |  |  |  |
Prepaid expenses and other current assets |  |  |  |  |  |  |  |  |
Security deposits and other assets |  |  |  |  |  |  |  |  |
Goodwill |  |  |  |  |  |  |  |  |
In-process R&D |  |  |  |  |  |  |  |  |
Property and equipment |  |  |  |  |  |  |  |  |
Accounts payable and accrued expenses |  |  |  |  |  |  |  |  |
Loans payable, related parties |  |  |  |  |  |  |  |  |
Loans payable |  |  |  |  |  |  |  |  |
Total purchase price |  |  |  |  |  |  |  |  |
Purchase price consisted of: |  |  |  |  |  |  |  |  |
Members' equity issued to acquire the asset and liabilities of IRX |  |  |  |  |  |  |  |  |
Contingent consideration |  |  |  |  |  |  |  |  |
Total purchase price |  |  |  |  |  |  |  |  |

X
- Definition Accounts payable and accrued expenses, Non-cash investing and financing activities. + References No definition available. + Details
Name: | NTN_AccountsPayableAndAccruedExpensesAcquiredNonCashInvestingAndFinancingActivities
Namespace Prefix: | NTN_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Assets acquired and liabilities assumed [Abstract] + References No definition available. + Details
Name: | NTN_AssetsAcquiredAndLiabilitiesAssumedNonCashInvestingAndFinancingAbstract
Namespace Prefix: | NTN_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Cash acquired, assets acquired, non cash investing activities. + References No definition available. + Details
Name: | NTN_CashAcquiredNonCashInvestingAndFinancingActivities
Namespace Prefix: | NTN_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- References No definition available. + Details
Name: | NTN_CashAndCashEquivalentsRestrictedCashAtCarryingValueAbstract
Namespace Prefix: | NTN_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Contingent consideration, Non-cash investing and financing activities. + References No definition available. + Details
Name: | NTN_ContingentConsiderationOfPurchaseAcquiredNonCashInvestingAndFinancingActivities
Namespace Prefix: | NTN_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Conversion of loans payable and interest into members' equity. + References No definition available. + Details
Name: | NTN_ConversionOfLoansPayableAndInterestIntoMembersEquity
Namespace Prefix: | NTN_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Exchange of Series A, B and C preferred stock for common stock + References No definition available. + Details
Name: | NTN_ExchangeOfSeriesBAndCPreferredStockForCommonStock
Namespace Prefix: | NTN_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Goodwill, Non-cash investing and financing activities. + References No definition available. + Details
Name: | NTN_GoodwillAcquiredNonCashInvestingandFinancingActivities
Namespace Prefix: | NTN_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Increase decrease in lease liability. + References No definition available. + Details
Name: | NTN_IncreaseDecreaseInLeaseLiability
Namespace Prefix: | NTN_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition In-process Research and development, Non cash financing and investing. + References No definition available. + Details
Name: | NTN_InprocessResearchAndDevelopmentNonCashInvestingAndFinancingActivities
Namespace Prefix: | NTN_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Investor deposits for sale of members' equity. + References No definition available. + Details
Name: | NTN_InvestorDepositsForSaleOfMembersEquity
Namespace Prefix: | NTN_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Loans payable, Non-cash investing and financing activities. + References No definition available. + Details
Name: | NTN_LoansPayableLiabilitiesAcquiredNonCashInvestingAndAssetsAcquired
Namespace Prefix: | NTN_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Loans payable, related parties, Non-cash investing and financing activities. + References No definition available. + Details
Name: | NTN_LoansPayableRelatedPartiesAcquiredNonCashInvestingAndFinancingActivities
Namespace Prefix: | NTN_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Loss on operating sublease. + References No definition available. + Details
Name: | NTN_LossOnOperatingSublease
Namespace Prefix: | NTN_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Members' equity issued to acquire the asset and liabilities of IRX, Non-cash investing and financing activities. + References No definition available. + Details
Name: | NTN_MembersEquityIssuedToAcquireAssetAndLiabilitiesNonCashInvestingAndFinancingActivities
Namespace Prefix: | NTN_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Purchase of leasehold improvements. + References No definition available. + Details
Name: | NTN_PaymentsToLeaseholdImprovements
Namespace Prefix: | NTN_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Payments to patents costs. + References No definition available. + Details
Name: | NTN_PaymentsToPatentCosts
Namespace Prefix: | NTN_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Prepaid expenses and other current assets - Non-cash investing and financing activities. + References No definition available. + Details
Name: | NTN_PrepaidExpensesAndOtherCurrentAssetsNonCashInvestingActivites
Namespace Prefix: | NTN_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Proceeds from the collection of subscriptions receivable. + References No definition available. + Details
Name: | NTN_ProceedsFromCollectionOfSubscriptionsReceivable
Namespace Prefix: | NTN_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Proceeds from investor deposits. + References No definition available. + Details
Name: | NTN_ProceedsFromInvestorDeposits
Namespace Prefix: | NTN_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Property and equipment, non cash investing and financing activities. + References No definition available. + Details
Name: | NTN_PropertyAndEquipmentAssetsAcquiredNonCashInvestingAndFinancingActivities
Namespace Prefix: | NTN_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Purchase price, Non-cash investing and financing activities. + References No definition available. + Details
Name: | NTN_PurchasePriceAssetsAndLiabilitiesAcquiredNonCashInvestingAndFinancingActivities
Namespace Prefix: | NTN_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Purchase price, Non-cash investing and financing activities. + References No definition available. + Details
Name: | NTN_PurchasePriceAssetsAndLiabilitiesAcquiredNonCashInvestingAndFinancingActivity
Namespace Prefix: | NTN_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Purchase price consisted, Non-cash investing and financing activities [Abstract] + References No definition available. + Details
Name: | NTN_PurchasePriceConsistedOfAssetsAndLiabilitiesAcquiredAbstract
Namespace Prefix: | NTN_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Security deposits and other assets, Non-cash investing and financing activities. + References No definition available. + Details
Name: | NTN_SecurityDepositsAndOtherAssetsNonCashInvestingFinancingActivities
Namespace Prefix: | NTN_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The sum of adjustments which are added to or deducted from net income or loss, including the portion attributable to noncontrolling interest, to reflect cash provided by or used in operating activities, in accordance with the indirect cash flow method. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 28 -URI http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585 + Details
Name: | us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 946 -SubTopic 210 -Section 45 -Paragraph 20 -URI http://asc.fasb.org/extlink&oid=118262064&loc=SL116631418-115840 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.1) -URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 946 -SubTopic 210 -Section 45 -Paragraph 21 -URI http://asc.fasb.org/extlink&oid=118262064&loc=SL116631419-115840 + Details
Name: | us-gaap_Cash
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition The cash inflow associated with the acquisition of a business when the cash held by the acquired business exceeds the cash payments to acquire the business. + References No definition available. + Details
Name: | us-gaap_CashAcquiredInExcessOfPaymentsToAcquireBusiness
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 50 -Paragraph 8 -URI http://asc.fasb.org/extlink&oid=121583591&loc=SL98516268-108586 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 24 -URI http://asc.fasb.org/extlink&oid=121586364&loc=d3e3521-108585 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 4 -URI http://asc.fasb.org/extlink&oid=121586364&loc=d3e3044-108585 + Details
Name: | us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 830 -SubTopic 230 -Section 45 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=98513438&loc=d3e33268-110906 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 24 -URI http://asc.fasb.org/extlink&oid=121586364&loc=d3e3521-108585 + Details
Name: | us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 360 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 28 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585 + Details
Name: | us-gaap_DepreciationAndAmortization
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=121583591&loc=d3e4297-108586 + Details
Name: | us-gaap_IncomeTaxesPaidNet
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 28 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585 + Details
Name: | us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Amount of increase (decrease) in operating liabilities classified as other. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 28 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585 + Details
Name: | us-gaap_IncreaseDecreaseInOtherOperatingLiabilities
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Amount of increase (decrease) of consideration paid in advance for other costs that provide economic benefits in future periods. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 28 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585 + Details
Name: | us-gaap_IncreaseDecreaseInPrepaidExpensesOther
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition The increase (decrease) during the reporting period in security deposits. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 28 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585 + Details
Name: | us-gaap_IncreaseDecreaseInSecurityDeposits
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=121583591&loc=d3e4297-108586 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 17 -Subparagraph (d) -URI http://asc.fasb.org/extlink&oid=121586364&loc=d3e3367-108585 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 25 -Subparagraph (e) -URI http://asc.fasb.org/extlink&oid=121586364&loc=d3e3536-108585 + Details
Name: | us-gaap_InterestPaidNet
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 24 -URI http://asc.fasb.org/extlink&oid=121586364&loc=d3e3521-108585 + Details
Name: | us-gaap_NetCashProvidedByUsedInFinancingActivities
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 24 -URI http://asc.fasb.org/extlink&oid=121586364&loc=d3e3521-108585 + Details
Name: | us-gaap_NetCashProvidedByUsedInInvestingActivities
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 25 -URI http://asc.fasb.org/extlink&oid=121586364&loc=d3e3536-108585 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 24 -URI http://asc.fasb.org/extlink&oid=121586364&loc=d3e3521-108585 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 28 -URI http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585 + Details
Name: | us-gaap_NetCashProvidedByUsedInOperatingActivities
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 220 -SubTopic 10 -Section 45 -Paragraph 1A -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580 Reference 2: http://www.xbrl.org/2003/role/exampleRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 31 -URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8924-108599 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 250 -SubTopic 10 -Section 50 -Paragraph 11 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794 Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 942 -SubTopic 220 -Section S99 -Paragraph 1 -Subparagraph (SX 210.9-04(22)) -URI http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 250 -SubTopic 10 -Section 50 -Paragraph 11 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 32 -Subparagraph (f) -URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599 Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 205 -SubTopic 20 -Section 50 -Paragraph 7 -URI http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760 Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 250 -SubTopic 10 -Section 50 -Paragraph 4 -URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22595-107794 Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 220 -SubTopic 10 -Section 45 -Paragraph 1B -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=121641772&loc=SL7669625-108580 Reference 10: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 22 -URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599 Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 944 -SubTopic 220 -Section S99 -Paragraph 1 -Subparagraph (SX 210.7-04(18)) -URI http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263 Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 220 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03(20)) -URI http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227 Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 28 -URI http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585 Reference 14: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 250 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (b)(2) -URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794 Reference 15: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 250 -SubTopic 10 -Section 50 -Paragraph 9 -URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22663-107794 Reference 16: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 825 -SubTopic 10 -Section 50 -Paragraph 28 -Subparagraph (f) -URI http://asc.fasb.org/extlink&oid=75031198&loc=d3e14064-108612 Reference 17: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 30 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599 Reference 18: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 250 -SubTopic 10 -Section 50 -Paragraph 3 -URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22583-107794 Reference 19: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08(g)(1)(ii)) -URI http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690 Reference 20: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 45 -Paragraph 60B -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=121326447&loc=SL5780133-109256 Reference 21: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 323 -SubTopic 10 -Section 50 -Paragraph 3 -Subparagraph (c) -URI http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571 Reference 22: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 32 -Subparagraph (c) -URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599 Reference 23: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 250 -SubTopic 10 -Section 50 -Paragraph 8 -URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22658-107794 + Details
Name: | us-gaap_NetIncomeLoss
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_NoncashInvestingAndFinancingItemsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 13 -Subparagraph (c) -URI http://asc.fasb.org/extlink&oid=121586364&loc=d3e3213-108585 + Details
Name: | us-gaap_PaymentsToAcquirePropertyPlantAndEquipment
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition The cash inflow from the issuance of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 14 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=121586364&loc=d3e3255-108585 + Details
Name: | us-gaap_ProceedsFromConvertibleDebt
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition The cash inflow from the issuance of common stock, preferred stock, treasury stock, stock options, and other types of equity. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 14 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=121586364&loc=d3e3255-108585 + Details
Name: | us-gaap_ProceedsFromIssuanceOrSaleOfEquity
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Cash received from principal payments made on loans related to operating activities. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 25 -Subparagraph (c) -URI http://asc.fasb.org/extlink&oid=121586364&loc=d3e3536-108585 + Details
Name: | us-gaap_ProceedsFromLoans
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition The cash inflow from a long-term borrowing made from related parties where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Proceeds from Advances from Affiliates. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 14 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=121586364&loc=d3e3255-108585 + Details
Name: | us-gaap_ProceedsFromRelatedPartyDebt
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Amount of cash restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 50 -Paragraph 8 -URI http://asc.fasb.org/extlink&oid=121583591&loc=SL98516268-108586 Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 942 -SubTopic 210 -Section S99 -Paragraph 1 -Subparagraph (SX 210.9-03(1)(a)) -URI http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878 Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 944 -SubTopic 210 -Section S99 -Paragraph 1 -Subparagraph (SX 210.7-03(a)(2)) -URI http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910 + Details
Name: | us-gaap_RestrictedCash
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Amount of cash and cash equivalents restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 944 -SubTopic 210 -Section S99 -Paragraph 1 -Subparagraph (SX 210.7-03(a)(2)) -URI http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(1)) -URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 50 -Paragraph 8 -URI http://asc.fasb.org/extlink&oid=121583591&loc=SL98516268-108586 Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 942 -SubTopic 210 -Section S99 -Paragraph 1 -Subparagraph (SX 210.9-03(1)(a)) -URI http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878 Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 4 -URI http://asc.fasb.org/extlink&oid=121586364&loc=d3e3044-108585 + Details
Name: | us-gaap_RestrictedCashAndCashEquivalents
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Amount of noncash expense for share-based payment arrangement. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 28 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585 + Details
Name: | us-gaap_ShareBasedCompensation
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_SupplementalCashFlowInformationAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | srt_ConsolidatedEntitiesAxis=NTN_BrooklynImmunotherpeuticsLLCMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_StatementScenarioAxis=NTN_SuccessorsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_StatementScenarioAxis=NTN_PredecessorsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |